Endocrinology Billing for the Specialty That Runs on Feedback Loops

Endocrinology billing is driven by frequency rules, stimulation and suppression test panels, CGM and insulin-pump device billing, and thyroid procedure bundling. ProvidaRCM manages the full medical billing service revenue cycle for endocrinology practices, from eligibility verification and prior authorization through diabetes and thyroid management, hormone axis testing, device billing, and denial recovery.

99%
Clean Claim Rate
24
Days in A/R
96%
Net Collection Rate
The endocrine axis - the subject of every claim

Endocrinology regulates the body through feedback loops. Billing it well means tracking the tests, devices, and procedures that sit on each axis, each with its own frequency and bundling rules.

Hypothalamus
Origin
releasing hormones
TSH
Thyroid
Thyroid panels, FNA, ultrasound
CORT
Adrenal
Stimulation, suppression tests
HbA1c
Pancreas
Diabetes, CGM, insulin pumps
LH/FSH
Gonads
Hormone panels, replacement
negative feedback closes the loop
Why this is the hero of endocrinology billing: Each gland on the axis has a different test family, frequency limit, and device or procedure rule. We track all four, and the feedback between them, so nothing falls through.

Endocrine Testing, Frequency Limits, and the Labs That Drive Revenue

The defining complexity of endocrinology billing is the testing layer: hormone panels, stimulation and suppression tests, and routine labs that each carry frequency rules and NCCI bundling traps.

The testing complexity

Endocrinology runs on labs. HbA1c, TSH, free T4, cortisol, stimulation and suppression panels, and hormone assays each follow their own frequency limits and bundling rules. A claim for the right test with the wrong frequency, or two labs that bundle under NCCI, denies before medical-necessity review.

83036 Hemoglobin A1c

HbA1c is typically covered every 90 days for controlled diabetes, more often with documented medical necessity. We track last-test dates and flag frequency before submission.

84443 + 84439 TSH and Free T4

TSH and free T4 bundle under NCCI edits in some payer configurations; we confirm whether both are separately billable for the date of service and document distinct medical necessity.

80400 - 80440 Stimulation / suppression panels

Endocrine stimulation and suppression testing uses panel codes that require documented medical necessity and proper panel construction. We verify the panel matches the agents and samples drawn.

E03.9 Vague ICD-10 risk

Unspecified endocrine codes such as E03.9 hypothyroidism trigger denials when a more specific code exists. We code to the highest specificity the record supports.

Frequency

Laboratory frequency tracking

HbA1c, TSH, and routine hormone labs carry per-patient frequency limits. We track last-service dates and hold claims inside the window unless a documented exception qualifies the test.

83036 - 90 days - 84443 - 84439
NCCI

Lab bundling edits

TSH and free T4, and several endocrine panels, bundle under NCCI edits. We screen every encounter against current edits so bundled combinations are not billed together.

84439 + 84443 - modifier 59 / XS
~$12-18K

Lost per endocrinologist yearly from unbilled CGM interpretation

2.49%Starting Rate
500+Providers Supported
40+Specialties Served
99%Clean Claim Rate
24Days in A/R
2.1%Denial Rate
96%Net Collection Rate
24/7Operational Coverage
2.49%Starting Rate
500+Providers Supported
40+Specialties Served
99%Clean Claim Rate
24Days in A/R
2.1%Denial Rate
96%Net Collection Rate
24/7Operational Coverage

Endocrinology Services We Bill

From diabetes management and continuous glucose monitoring through thyroid procedures, hormone axis testing, and remote care, we bill the full range of services endocrinology practices deliver.

E/M

Diabetes and Office Visits

Office E/M for diabetes and complex endocrine management, with the complexity add-on for longitudinal care and modifier 25 when a procedure is same-day.

99202-99215, G2211, +mod 25
HbA1c

HbA1c and Diabetes Labs

Hemoglobin A1c, glucose, and diabetes-related labs billed with frequency tracking and the diabetes diagnosis that supports medical necessity.

83036, 83037, 82947
CGM

Continuous Glucose Monitoring

CGM setup, training, and data interpretation, with the written report 95251 requires and the DME supply allowance billed alongside the device.

95249, 95250, 95251 + E2102/E2103
PUMP

Insulin Pump and Supplies

External insulin infusion pump billing with infusion sets, reservoirs, and insulin J-codes for pump administration, plus the KX coverage modifier.

E0784, A4224, A4225, J1817 + KX
TSH

Thyroid Lab Panels

TSH, free T4, and total T4 with NCCI bundling awareness and documented distinct medical necessity where both are billed.

84443, 84439, 84436
US

Thyroid Ultrasound and FNA

Thyroid ultrasound and percutaneous needle biopsy, with NCCI bundling between 76536 and 60100 managed with modifier 59 where diagnostic and procedural care are distinct.

76536, 60100, 60300, 10005
STIM

Stimulation and Suppression Tests

Endocrine stimulation and suppression panel coding, with medical necessity and proper panel construction documented for the agents and samples drawn.

80400 - 80440, 80415
RPM

Remote and Chronic Care

Remote patient monitoring, chronic care management, diabetes self-management training, and medical nutrition therapy for longitudinal diabetes care.

99453/54/57/58, 99490, G0108, G0270
HORM

Hormone Replacement Therapy

Testosterone, estradiol, and replacement therapy management with the lab and E/M coding that supports ongoing endocrine treatment.

84403, 82670, 80415

Endocrinology Code Reference

Common CPT, HCPCS, ICD-10-CM, and modifier codes used in endocrinology billing. Verify every code and description against current CPT, HCPCS, ICD-10-CM, NCCI, and payer policy before submission.

CodeDescriptionBilling Consideration
83036Hemoglobin glycosylated A1c (HbA1c)Typically every 90 days for controlled diabetes; more frequent with documented medical necessity. Track last-test date.
83037HbA1c using a home device (cleared by FDA)Used when the test is run on a patient's cleared home device; verify payer acceptance.
84443Thyroid stimulating hormone (TSH) assayCore thyroid lab; may bundle with free T4 (84439) under NCCI edits, confirm distinct medical necessity.
84439Thyroxine, free (free T4)Bundling risk with 84443; use modifier 59 or XS only when documentation supports distinct diagnostic purpose.
95249CGM setup and training, patient-provided deviceOne-time per device; not billed with 95250 for the same period.
95251CGM data analysis and interpretation, per 30 daysRequires a written interpretation report; widely under-billed. Medicare caps frequency for insulin-dependent diabetics.
76536Ultrasound, soft tissue of head and neck (thyroid)LCD L33822 requires a documented clinical indication; may bundle with 60100 when used as procedural guidance.
60100Percutaneous needle biopsy of thyroidOften requires prior authorization; use modifier 59 with 76536 only when ultrasound is diagnostic and distinct.
10005Fine needle aspiration, with ultrasound guidanceFNA family codes 10005 through 10012; select by the number of lesions and guidance type.
80400-80440Endocrine stimulation and suppression testing panelsPanel codes require medical necessity and correct panel construction matching the agents and samples drawn.
E0784External ambulatory insulin infusion pump (HCPCS)Requires KX modifier and documented clinical criteria including C-peptide and glucose-testing history.
J1817Insulin for administration through DME, per 50 units (HCPCS)Billed with the pump; JK for 1-month or JL for 3-month supply; coinsurance capped at $35 monthly.

CPT and HCPCS codes and descriptions are summarized for reference. Code selection must be supported by provider documentation and verified against the current CPT, HCPCS, NCCI, and payer policy. Requirements may vary by payer, plan, service, and applicable regulations.

Diabetes Care, CGM, and Insulin-Pump DME Billing

Diabetes is the largest revenue stream in endocrinology, and its device billing layer, CGM interpretation, and insulin-pump supplies carry the highest denial and under-billing risk in the specialty.

Continuous glucose monitoring (CGM)

CGM billing spans setup, training, and monthly data interpretation. The interpretation code 95251 is the most consistently under-billed service in endocrinology because it requires a written report most practices never generate.

95249 CGM setup and training, patient-provided device. One-time per device.Do not bill with 95250 for the same period.
95250 CGM setup and training, office-provided device. Once per 30 days.Practice supplies the device and trains the patient.
95251 CGM data download, analysis, and interpretation. Per 30 days.Requires a written interpretation report. Medicare limits to insulin-dependent diabetics.
E2102 / E2103 CGM receiver, adjunctive and non-adjunctive.DME device code billed with the supply allowance.
A4238 / A4239 CGM supply allowance, monthly.Billed alongside the receiver; verify coverage criteria.
95251 under-billing: We build the written interpretation report into the workflow so the monthly interpretation is captured, not silently dropped. Estimated $12,000 to $18,000 per endocrinologist per year is left on the table from this one code alone.

Insulin pumps and supplies

Insulin-pump billing is DME and follows coverage LCDs with documented clinical criteria. The KX modifier attests that all criteria are met, and insulin for pump administration uses its own J-code family.

E0784 External ambulatory insulin infusion pump.Requires KX and documented criteria including C-peptide and glucose-testing history.
A4224 Insulin pump infusion sets, per week.Consumable supply billed on the pump cycle.
A4225 Insulin pump reservoirs / cartridge.Pair with infusion sets on the same claim cycle.
J1817 Insulin for DME pump administration, per 50 units.JK for 1-month or JL for 3-month supply.
KX Coverage criteria met modifier.Required on the pump and insulin to attest LCD L33794 criteria.
$35 insulin cap: Patient cost-sharing for insulin is capped at $35 per month under current rules. We reconcile coinsurance on every pump claim so the cap is applied and no patient is over-billed.

Thyroid Procedures and NCCI Bundling

Thyroid ultrasound and biopsy bundle under NCCI edits, and thyroid procedures trigger prior authorization. We separate diagnostic from procedural care and document the distinctness so both can be billed.

The thyroid procedure set

Thyroid care moves from diagnostic ultrasound through fine needle aspiration and cyst management. Each step has a code, a clinical indication requirement, and an LCD or authorization gate.

01
Diagnostic ultrasound 76536
Thyroid and soft-tissue ultrasound. LCD L33822 requires a documented clinical indication before the test is ordered.
02
Percutaneous needle biopsy 60100
Tissue sampling for nodule workup. Frequently requires prior authorization and a supporting diagnosis such as a documented nodule or C73.
03
Fine needle aspiration 10005
FNA with ultrasound guidance, 10005 through 10012. Select by lesion count and guidance type.
04
Cyst aspiration 60300
Aspiration or injection of a thyroid cyst. Documented volume and pathology drive downstream coding.

NCCI bundling between ultrasound and biopsy

76536 and 60100 bundle under NCCI edits when the ultrasound is used as procedural guidance for the biopsy. Both are billable only when the ultrasound is a separate diagnostic study.

76536 + 60100
Bundle by default. Bill separately with modifier 59 or XS only when ultrasound is a distinct diagnostic study and the biopsy is a separate procedural encounter.
84439 + 84443
Free T4 and TSH may bundle. Modifier 59 only when both serve a distinct diagnostic purpose that is documented.
99214 + 95251
Same-day E/M and CGM interpretation. Modifier 25 on the E/M when the visit is significant and separately identifiable from the data review.
Never use a modifier to bypass an edit that the documentation does not support. That is the fastest route to an audit and recoupment.
LCD L33822 governs thyroid ultrasound clinical indications and LCD L33794 governs insulin pump coverage criteria including C-peptide and HbA1c thresholds. We check both before submission.

Endocrinology Denial Patterns We Fix

Endocrinology denials cluster around missing reports, missing modifiers, vague ICD-10, and DME coverage gaps. We prevent each pattern before submission and recover the ones already on the books through dedicated denial management.

PATTERN 01

95251 dropped without a written report

CGM data interpretation requires a written report. Practices download the data but never document the interpretation, so the monthly code is never billed.

Our fixWe generate the interpretation report as part of the visit workflow so 95251 is captured every 30 days.
PATTERN 02

Missing modifier 25 on same-day E/M

An E/M with a thyroid biopsy or CGM setup on the same day denies when modifier 25 is absent, even when both services were clearly delivered.

Our fixModifier 25 is applied automatically when a procedure shares the encounter, with documentation supporting both.
PATTERN 03

Vague unspecified ICD-10 codes

E03.9 hypothyroidism unspecified and similar codes deny when a more specific code exists in the record but was never selected.

Our fixWe code to the highest specificity the documentation supports and query the provider before defaulting to unspecified.
PATTERN 04

NCCI bundle without a modifier

76536 and 60100, and 84439 and 84443, deny together when billed without a documenting a distinct service through modifier 59 or XS.

Our fixEvery encounter is screened against current NCCI edits before submission so distinct services carry the right modifier.
PATTERN 05

DME coverage gaps on pumps and CGM

Insulin pumps and CGM receivers deny when KX criteria, C-peptide, or glucose-testing history are not documented in the claim.

Our fixWe verify LCD L33794 and L33822 criteria and attach KX with the supporting documentation before submission.
PATTERN 06

Prior authorization gaps on biopsy

Thyroid biopsy 60100 frequently requires prior authorization that was never obtained, producing an automatic denial with no appeal path.

Our fixWe flag authorization-required procedures at scheduling and obtain approval before the encounter is billed.

How We Run Your Endocrinology Revenue Cycle

A disciplined four-stage pipeline built around the testing, device, and procedure rules that make endocrinology billing different from every other specialty.

01Front-end

Capture and verify

Stage gateNothing ships unflagged
02Coding

Code and submit

  • Specialty-specific medical coding to highest documented specificity
  • Modifiers 25, 59, XS, and KX applied only where supported
  • Panel construction matched to the agents and samples drawn
Stage gateClaims pass the pre-submission scrub
03Posting

Post and reconcile

  • EOB-driven payment posting, line by line
  • $35 insulin coinsurance cap applied on every pump claim
  • CGM and insulin-pump DME reconciled to the device record
Stage gateShortfalls flagged for appeal
04Recovery

Appeal and recover

  • Specialty-specific appeals for denied 95251 and bundled 76536
  • Root-cause analysis fed back to the front-end
  • Prevention built into the next claim cycle
Stage gateDenials do not recur

Accounts Receivable and Payment Posting

Endocrinology A/R spans Medicare, commercial payers with prior authorization, and DME carriers. We post every payment against the EOB, reconcile patient statements where the $35 insulin cap applies, apply out-of-network rules where appropriate, and chase every shortfall.

EOB

EOB-driven payment posting

Every remittance is posted against the original charge, with contractual adjustments, patient responsibility, and the insulin coinsurance cap reconciled line by line.

835 / 837$35 capAdjustments
DME

DME and CGM reconciliation

Pump and CGM claims are tracked across the supply cycle, with monthly A4238 / A4239 allowances and insulin J-codes reconciled to the device record.

E0784A4238J1817
A/R

Aged A/R management

We work the 30, 60, 90, and 120-plus day buckets weekly, with payer-specific follow-up cadence and appeal letters built for endocrinology denial patterns.

30/60/90AppealsFollow-up

The Endocrinology RCM Capability Scorecard

Endocrinology is not internal medicine with thyroid labs added. The difference shows up in device billing, frequency rules, and modifiers.

ProvidaRCM

Endocrinology RCM

Built around CGM interpretation, pump DME, and the frequency rules that drive endocrinology revenue.

99%
Clean claims
24d
Days in A/R
96%
Net collection

CGM 95251 interpretation captured monthly

Written report built into the visit workflow so the code is billed every 30 days.

Insulin-pump DME with KX and LCD checks

L33794 coverage criteria verified before the pump and insulin J-codes are submitted.

NCCI screening on 76536 + 60100

Every thyroid encounter screened against current edits before submission.

Lab frequency tracking for HbA1c and TSH

Per-patient test windows tracked so frequency denials are prevented.

$35 insulin coinsurance cap applied

Reconciled on every pump claim so no patient is over-billed.

Thyroid biopsy prior authorization

Flagged at scheduling and approved before the encounter is billed.

Endocrinology capability score94 / 100
Generic Billing

Off-the-shelf RCM

Treats endocrinology like a primary care workflow with thyroid labs added. Benchmarked against typical industry averages.

95%
Clean claims
30d+
Days in A/R
90%
Net collection

CGM 95251 often unbilled

Data downloaded, interpretation report never generated or captured.

DME coverage criteria rarely checked

KX modifier and C-peptide history gaps produce automatic denials.

NCCI bundling left to the payer

Bundled 76536 and 60100 claims deny and are rarely appealed.

No lab frequency logic

HbA1c and TSH claims submitted inside the window without tracking.

$35 insulin cap frequently missed

Patients over-billed on coinsurance, triggering disputes and churn.

Retroactive authorization denials

Thyroid biopsy denied with no appeal path because approval was never obtained.

Endocrinology capability score56 / 100

Why Endocrinology Practices Choose ProvidaRCM

We run the full revenue cycle for endocrinology practices, with the specialty knowledge to bill the testing, devices, and procedures other firms drop. See how we compare across our full range of specialty billing services.

SPEC

Endocrinology-native coders

Our coders know the stimulation and suppression panel families, the CGM and pump DME rules, and the NCCI edits that govern thyroid procedures.

DME

Device billing expertise

We bill CGM, insulin pumps, and the monthly supply allowances as a connected cycle, not as one-off DME claims that lose the follow-on revenue.

RPM

Remote and chronic care capture

RPM, CCM, diabetes self-management training, and medical nutrition therapy are billed in full, so longitudinal diabetes care is not quietly volunteered.

FREQ

Frequency-aware lab billing

We track HbA1c, TSH, and hormone lab windows per patient so frequency denials are prevented and documented exceptions are captured.

APL

Denial recovery built in

Every denial is appealed with specialty-specific reasoning and fed back as root-cause analysis so the same endocrinology denial does not recur.

REP

Transparent reporting

You see clean claim rate, days in A/R, net collection rate, and denial reasons by payer, with the CGM and pump cycle reported separately.

Is Your Endocrinology Practice Leaking Revenue?

If any of these are true, your current billing is quietly costing you. A free audit will show exactly how much.

You download CGM data but never bill 95251The monthly interpretation code is the most under-billed service in endocrinology.
Thyroid ultrasounds and biopsies deny togetherNCCI bundling between 76536 and 60100 is denying claims you could bill separately.
Insulin pump claims lack KX or LCD documentationCoverage criteria for E0784 and insulin J-codes are not being verified before submission.
You are using unspecified ICD-10 codes like E03.9Vague endocrine codes deny when a more specific diagnosis is documented in the record.
Lab frequency windows are not being trackedHbA1c and hormone test frequency limits are not monitored, so claims deny inside the window.
RPM, CCM, and DSMT are not billed consistentlyLongitudinal diabetes care programs are quietly volunteered instead of captured.
Your diabetes patients are shared with primary care and cardiologyCoordinated billing with family medicine, cardiology, and nephrology care teams prevents duplicate and dropped claims.

Endocrinology Billing FAQ

Common questions from endocrinology and diabetes practice owners about CGM, insulin pumps, thyroid procedures, and the billing rules that govern them.

TOPIC 01

Endocrine Testing

Labs, frequency, and NCCI bundling across the hormone panel families.

HbA1c 83036 is typically covered every 90 days for a controlled diabetic patient. More frequent testing is allowed when medical necessity is documented, such as a recent medication change or uncontrolled glucose. We track the last-test date per patient and flag a claim before it is submitted inside the frequency window.

TSH 84443 and free T4 84439 can bundle under NCCI edits in some payer configurations. Both are billable on the same encounter only when distinct medical necessity for each is documented, supported by modifier 59 or XS. We confirm whether both are separately billable for the specific date of service before submission.

Endocrine stimulation and suppression testing uses panel codes in the 80400-80440 range. Each panel must match the agents administered and the samples drawn, with documented medical necessity. We verify the panel construction against the order and the lab record so the code reflects what was actually performed.

Codes like E03.9 unspecified hypothyroidism deny when a more specific code exists in the documentation, because payers require the highest specificity supported by the record. We code to the documented type and complication, and we query the provider before defaulting to an unspecified code.

TOPIC 02

Diabetes & CGM

CGM, insulin pumps, supplies, and the $35 insulin cap.

95249 is one-time CGM setup and training with a patient-provided device. 95250 is setup and training with an office-provided device, billable once per 30 days. 95251 is the monthly data download, analysis, and interpretation, and it requires a written interpretation report. The three are not billed together for the same period.

Because 95251 requires a written interpretation report and most practices download the CGM data without documenting a separate interpretation. We build the report into the visit workflow so the monthly code is captured. An endocrinologist can leave an estimated $12,000 to $18,000 per year on the table from this one code alone.

The pump itself is E0784, billed with the KX modifier attesting that LCD L33794 coverage criteria are met, including C-peptide and glucose-testing history. Infusion sets A4224 and reservoirs A4225 are billed as consumables, and insulin for pump administration uses J1817 with JK or JL for the supply duration.

Patient cost-sharing for insulin is capped at $35 per month under current rules. We reconcile the coinsurance on every pump and insulin claim so the cap is applied correctly and no patient is over-billed, while the practice still collects the full allowed amount from the payer.

TOPIC 03

Thyroid & Procedures

Ultrasound, biopsy, FNA, and the NCCI edits between them.

Ultrasound 76536 and needle biopsy 60100 bundle under NCCI edits when the ultrasound is used as procedural guidance for the biopsy. They are separately billable only when the ultrasound is a distinct diagnostic study, documented and supported by modifier 59 or XS. We screen every encounter against current edits before submission.

Thyroid biopsy 60100 frequently requires prior authorization, especially with commercial payers. We flag authorization-required procedures at scheduling and obtain approval before the encounter is billed, so the claim is not denied with no appeal path.

Medicare LCD L33822 defines the clinical indications that support a covered thyroid ultrasound. We confirm the documented indication matches the LCD before the test is ordered and billed, so the claim does not deny for lack of medical necessity.

TOPIC 04

Operations & A/R

Coding, denials, appeals, and the business of the practice.

When an E/M visit and a procedure such as a thyroid biopsy or CGM setup happen on the same day, modifier 25 is applied to the E/M only when the visit is significant and separately identifiable from the procedure. The documentation must support both. We apply the modifier automatically where the record supports it and hold the claim where it does not, querying the provider first.

Our starting rate is 2.49 percent of collected revenue, with no hidden fees. Pricing scales with practice size and complexity, and we scope the full revenue cycle, from front-end capture through denial recovery, in the initial consultation. The exact percentage is confirmed after a free billing audit.

Yes. We bill remote patient monitoring 99453/99454/99457/99458, chronic care management 99490, diabetes self-management training G0108/G0109, and medical nutrition therapy G0270. Longitudinal diabetes care is a revenue stream that generic billing companies routinely under-capture.

Bring Your Endocrinology Billing Onto a Managed Axis

Stop losing CGM interpretation, pump DME, and thyroid procedure revenue to denials you can prevent. Start with a free billing audit and a clear path to higher collections.

01

Free audit

We review your CGM, pump, and thyroid claim history and quantify what is leaking.

02

Consultation

You receive a written findings report and a scoped recovery plan with no obligation.

03

Onboard

We take over the full revenue cycle with endocrinology-native coders from day one.

2.49%
Starting Rate
99%
Clean Claim Rate
24 days
Average A/R
96%
Net Collection